In addition, they introduced a diphtheria toxin receptor (DTR) fused to an enhanced green fluorescent protein (GFP) under the control of endogenous Lgr5 so that Lgr5 positive CRC stem cells can be selectively killed by administration of diphtheria toxin. The gene discussed is LGR5; the disease is colorectal carcinoma.